Why the study?
Does high-frequency atrial pacing from the right atrial appendage or coronary sinus ostium improve the termination of acute atrial fibrillation and atypical atrial flutter compared to observation?
Does high-frequency atrial pacing from the right atrial appendage or coronary sinus ostium improve the termination of acute atrial fibrillation and atypical atrial flutter compared to observation?
High-frequency pacing at the coronary sinus ostium or right atrial appendage is more effective than observation for terminating acute atypical atrial flutter and atrial fibrillation during EP studies.
Supports high-frequency pacing from RAA/CS-Os for acute AAFL/AF termination in EP studies; extends observational data with RCT confirmation.
BACKGROUND: The aim of this study was to assess the efficacy of high-frequency (HF) pacing from the right atrial appendage (RAA) or coronary sinus ostium (CS-Os) for the termination of acute atrial fibrillation (AF) and atypical atrial flutter (AAFL) during an electrophysiological (EP) study. METHODS: 128 episodes of acute fast atrial arrhythmias (FAAs; 93 AF and 35 AAFL) were analyzed in 110 patients. Patients were initially observed for 60s leading to spontaneous termination of 28 FAAs. The remaining 100 FAAs (70 AF) episodes were randomized to the following strategies: (A) pacing at RAA using up to 10 consecutive 20-Hz trains followed by the same stimulation protocol at CS-Os if RAA pacing failed, (B) pacing at CS-Os using the same stimulation protocol followed by HF pacing at RAA, or (C) observation up to 6 minutes ("no pacing"). RESULTS: The 20-Hz pacing at both RAA and CS-Os was associated with higher conversion of AAFL, as compared to strategy C (60% and 77% vs 11%; P < 0.05). Only HF pacing at CS-Os was superior to observation strategy for the conversion of AF (21% vs 4%; P < 0.05). CONCLUSIONS: The 20-Hz pacing protocol is superior to observation strategy for interruption of either acute AF or acute AAFL episodes; however, its efficacy is higher in AAFLs. These results can be helpful for the termination of acute atrial tachyarrhythmias during EPstudy and should be further evaluated in patients with implantable devices capable of antitachycardia pacing.
No takes yet. Share an insight, caveat, or question.
Шлевков et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: